Potassium Chloride
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Potassium Chloride
- Generic name
- POTASSIUM CHLORIDE
- Manufacturer
- PAI Holdings, LLC dba PAI Pharma
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- e848477f-b10d-4249-b322-b70cd6a062de
- SPL ID
- f5027a39-0ab3-4d01-9f7a-3737c7e8e852
- Version
- 7
- Effective date
- 2024-11-19
- Source export date
- 2026-11-06
- Source partition
- 7
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/824fe785252d7061429a95ddb6de517ee399ef628d34e8fdcc3591ded286ae33/drug-label-0007-of-0014.json.zip
- Source manifest SHA-256
- 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
- Import run
- 20261108T063105Z
- Imported at
- 2026-11-08 07:26:06
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 210766 | derived:openfda.application_number |
| application number | ANDA210766 | openfda.application_number | |
| brand name | Potassium Chloride | openfda.brand_name | |
| generic name | POTASSIUM CHLORIDE | openfda.generic_name | |
| manufacturer name | PAI Holdings, LLC dba PAI Pharma | openfda.manufacturer_name | |
| ndc | package | 0121-4948-00 | openfda.package_ndc |
| ndc | package | 0121-4948-50 | openfda.package_ndc |
| ndc | package | 0121-1896-00 | openfda.package_ndc |
| ndc | package | 0121-1896-30 | openfda.package_ndc |
| ndc | package | 0121-2847-40 | openfda.package_ndc |
| ndc | package | 0121-4948-15 | openfda.package_ndc |
| ndc | package | 0121-2847-50 | openfda.package_ndc |
| ndc | package | 0121-2847-00 | openfda.package_ndc |
| ndc | package | 0121-1896-50 | openfda.package_ndc |
| ndc | package | 0121-4948-80 | openfda.package_ndc |
| ndc | package | 0121-2847-16 | openfda.package_ndc |
| ndc | package | 0121-4948-94 | openfda.package_ndc |
| ndc | package | 0121-2847-15 | openfda.package_ndc |
| ndc | package | 0121-4948-40 | openfda.package_ndc |
| ndc | package | 0121-2847-80 | openfda.package_ndc |
| ndc | package | 0121-1896-40 | openfda.package_ndc |
| ndc | package | 0121-2847-94 | openfda.package_ndc |
| ndc | package | 0121-0948-16 | openfda.package_ndc |
| ndc | product | 0121-4948 | openfda.product_ndc |
| ndc | product | 0121-2847 | openfda.product_ndc |
| ndc | product | 0121-0948 | openfda.product_ndc |
| ndc | product | 0121-1896 | openfda.product_ndc |
| ndc11 | package | 00121284750 | derived:openfda.package_ndc |
| ndc11 | package | 00121189650 | derived:openfda.package_ndc |
| ndc11 | package | 00121189640 | derived:openfda.package_ndc |
| ndc11 | package | 00121284700 | derived:openfda.package_ndc |
| ndc11 | package | 00121494800 | derived:openfda.package_ndc |
| ndc11 | package | 00121094816 | derived:openfda.package_ndc |
| ndc11 | package | 00121494840 | derived:openfda.package_ndc |
| ndc11 | package | 00121284740 | derived:openfda.package_ndc |
| ndc11 | package | 00121189600 | derived:openfda.package_ndc |
| ndc11 | package | 00121494894 | derived:openfda.package_ndc |
| ndc11 | package | 00121494880 | derived:openfda.package_ndc |
| ndc11 | package | 00121189630 | derived:openfda.package_ndc |
| ndc11 | package | 00121494850 | derived:openfda.package_ndc |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
5 WARNINGS AND PRECAUTIONS Gastrointestinal Irritation : Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation if administered undiluted. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Pharmaceutical Associates, Inc. at 1-800-845-8210 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.